Found: 44
Select item for more details and to access through your institution.
Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 4, p. 172, doi. 10.1002/acr2.11641
- By:
- Publication type:
- Article
Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04059-w
- By:
- Publication type:
- Article
3T chemical shift‐encoded MRI: Detection of altered proximal femur marrow adipose tissue composition in glucocorticoid users and validation with magnetic resonance spectroscopy.
- Published in:
- Journal of Magnetic Resonance Imaging, 2019, v. 50, n. 2, p. spcone, doi. 10.1002/jmri.26586
- By:
- Publication type:
- Article
3T chemical shift-encoded MRI: Detection of altered proximal femur marrow adipose tissue composition in glucocorticoid users and validation with magnetic resonance spectroscopy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3 Tesla MRI detects deterioration in proximal femur microarchitecture and strength in long-term glucocorticoid users compared with controls.
- Published in:
- 2015
- By:
- Publication type:
- journal article
4336 Renal Tubular Complement C9 Deposition is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
- Published in:
- American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.927418
- By:
- Publication type:
- Article
Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population‐Based Registry.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 5, p. 1007, doi. 10.1002/acr.24960
- By:
- Publication type:
- Article
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Accelerating Medicines Partnership: Organizational Structure and Preliminary Data From the Phase 1 Studies of Lupus Nephritis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial.
- Published in:
- Annals of Internal Medicine, 2005, v. 142, n. 12, p. 953, doi. 10.7326/0003-4819-142-12_Part_1-200506210-00004
- By:
- Publication type:
- Article
High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patients.
- Published in:
- Frontiers in Epidemiology, 2024, p. 1, doi. 10.3389/fepid.2024.1334859
- By:
- Publication type:
- Article
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 772, doi. 10.1093/rheumatology/kead292
- By:
- Publication type:
- Article
Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program.
- Published in:
- Rheumatology, 2023, v. 62, n. 8, p. 2845, doi. 10.1093/rheumatology/keac703
- By:
- Publication type:
- Article
Whole blood drug levels do not correlate with QTc intervals in hydroxychloroquine-treated systemic lupus erythematosus patients.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 450, doi. 10.1093/rheumatology/keac245
- By:
- Publication type:
- Article
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4335, doi. 10.1093/rheumatology/keac067
- By:
- Publication type:
- Article
Corrigendum to: Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
A Woman With Painful Digital Ulcers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 12, p. 1971, doi. 10.1002/art.41450
- By:
- Publication type:
- Article
The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 10, p. 2006, doi. 10.1002/art.40192
- By:
- Publication type:
- Article
Treatment of Systemic Lupus Erythematosus.
- Published in:
- Bulletin of the Hospital for Joint Diseases, 2013, v. 71, n. 3, p. 208
- By:
- Publication type:
- Article
Treatment of ANCA-associated Systemic Vasculitis.
- Published in:
- Bulletin of the NYU Hospital for Joint Diseases, 2006, v. 64, n. 1/2, p. 60
- By:
- Publication type:
- Article
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03395-6
- By:
- Publication type:
- Article
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03275-z
- By:
- Publication type:
- Article
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. N.PAG, doi. 10.1186/s13075-020-02282-0
- By:
- Publication type:
- Article
Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
- Published in:
- Rheumatology International, 2010, v. 30, n. 5, p. 591, doi. 10.1007/s00296-009-1020-6
- By:
- Publication type:
- Article
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
- Published in:
- Advances in Rheumatology, 2021, v. 61, n. 1, p. 1, doi. 10.1186/s42358-021-00222-3
- By:
- Publication type:
- Article
Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 11, p. 1611, doi. 10.1002/art.42941
- By:
- Publication type:
- Article
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 10, p. 1687, doi. 10.1002/art.42624
- By:
- Publication type:
- Article
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 8, p. 1407, doi. 10.1002/art.42489
- By:
- Publication type:
- Article
Fluctuation of Anti–Domain 1 and Anti–β<sub>2</sub>‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 6, p. 984, doi. 10.1002/art.42459
- By:
- Publication type:
- Article
Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 711, doi. 10.1002/art.42382
- By:
- Publication type:
- Article
Urine Proteomics and Renal Single‐Cell Transcriptomics Implicate Interleukin‐16 in Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 5, p. 829, doi. 10.1002/art.42023
- By:
- Publication type:
- Article
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
- Published in:
- Lupus, 2022, v. 31, n. 14, p. 1770, doi. 10.1177/09612033221128742
- By:
- Publication type:
- Article
Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review.
- Published in:
- Lupus, 2022, v. 31, n. 2, p. 261, doi. 10.1177/09612033221074920
- By:
- Publication type:
- Article
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
- Published in:
- Lupus, 2021, v. 30, n. 14, p. 2276, doi. 10.1177/09612033211062523
- By:
- Publication type:
- Article
C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature.
- Published in:
- Lupus, 2021, v. 30, n. 10, p. 1671, doi. 10.1177/09612033211027938
- By:
- Publication type:
- Article
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
- Published in:
- Lupus, 2020, v. 29, n. 11, p. 1353, doi. 10.1177/0961203320940776
- By:
- Publication type:
- Article
Rapid aneurysm growth and rupture in systemic lupus erythematosus.
- Published in:
- 2015
- By:
- Publication type:
- Case Study